Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Luxium Solutions’ $19 Million Acquisition of Inrad Optics
Lowenstein Sandler represented Inrad Optics, Inc. in the transaction. Inrad Optics, Inc. (OTCMKTS:INRD) a provider of advanced optical components, assemblies and systems, announced its definitive merger...
CIVC Partners’ Acquisition of Datavail Corp.
Kirkland & Ellis LLP served as legal counsel to CIVC, while Lowenstein Sandler LLP served as legal counsel to Catalyst Investors and Datavail on the transaction....